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Aims. Attention decit hyperactivity disorder (ADHD) is one of the most frequent neurocognitive impairments in neurobromatosis 
type 1 (NF1) and a well-known risk factor for intellectual dysfunction in general. Since NF1 is per se associated with intellectual 
diculties, this comorbidity may be crucial for the cognitive development of aected patients. In our study, we investigated if attention 
decits are associated with intellectual functioning in NF1 and if children with NF1 plus ADHD dier in their intellectual and 
attention proles from children aected by NF1-only or ADHD only. Methods. 111 children aged between 6 and 12 years (53 NF1 plus 
ADHD, 28 NF1-only, 30 ADHD-only) performed the German version of the intelligence test WISC-IV and a continuous performance 
test (T.O.V.A.) to assess attention functions. Parents completed questionnaires about everyday attention and executive functions 
(Conners 3®, BRIEF). Results. Children with NF1 plus ADHD showed signicantly lower intelligence test scores (full-scale IQ: 89.39 
[1.40]) than patients with NF1-only (full-scale IQ: 101.14 [1.98]; 푝 < .001), and intellectual functioning correlated signicantly 
with attention performance in NF1 (푝 < .001). As compared to NF1-only, attention, and executive functioning were impaired on 
several dimensions (T.O.V.A., Conners 3® and BRIEF) in NF1 plus ADHD. ADHD-only was associated with signicantly higher 
problem scores regarding hyperactivity/impulsivity and inattention (Conners 3®). NF1-only was associated with inattentiveness 
when compared to the normative sample of the T.O.V.A. Conclusion. NF1 is associated with variable attention problems. Severe 
attention decits appear to be a risk factor for intellectual dysfunction in NF1, more than NF1 without attention decit. NF1 plus 
ADHD presents a specic cognitive prole, which diers from that of NF1 and from neurotypical ADHD.
1. Introduction
Neurobromatosis type 1 (NF1) is an autosomal dominant 
single-gene disorder, aecting the nervous system. It has an 
incidence rate of one in 2600–3000 individuals. While approx-
imately 50% of NF1 cases are caused by an inherited defect of 
the NF1 gene, the remainder traces back to spontaneous muta-
tions [1].  
NF1 is characterized by a wide range of physical complica-
tions [1] and is considered to cause a variety of cognitive dys-
functions [2]. Apart from slightly decreased intelligence scores, 
academic underachievement (e.g., writing, reading, spelling, 
and arithmetic), language problems, memory decits, impaired 
visuospatial abilities, and executive problems [3], serious atten-
tion problems are one of the most prominent cognitive features 
in NF1 [2]. Over and above unspecic attention problems, up 
to 50% of all NF1 patients present ADHD-like symptoms and 
full the diagnostic criteria for attention decit hyperactivity 
disorder (ADHD) [2, 4–6] according to the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV) [7]. Since the 
ADHD-diagnosis is based exclusively upon behavioral criteria, 
ADHD-like symptoms in NF1 may consequentially be 
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diagnosed as ADHD, even if etiology and developmental course 
of these symptoms are unknown so far and the high prevalence 
does not suggest a simple comorbidity.
e etiology of attention deﬁcits in NF1-associated ADHD 
must be assumed to diﬀer from that in ADHD in neurotypical 
children without NF1 (ADHD-only). While genetic factors 
seem to explain a high percentage of phenotype variance in 
ADHD-only [8], the incidence of attention problems in patients 
with NF1 is far higher than in their healthy siblings or parents 
[4], arguing against an independent heredity of ADHD in NF1. 
Although probably situated at the endpoint of diﬀerent genetic 
pathways, the attention deﬁcits in both groups seem to be gen-
erated by a disturbance of the catecholaminergic metabolism 
in fronto-striatal brain structures. Recent studies suggest that 
neuroﬁbromin deﬁciencies lead to reduced dopamine signaling, 
which might be responsible not only for impairments in learn-
ing and memory [9], but even more so for attention problems 
in NF1 [10]. In a mouse model, Brown and colleagues could 
trace attention defects in NF1-mutant mice back to reduced 
dopamine levels and reduced postsynaptic dopamine signaling 
in the striatum. Striatal dopamine levels could be normalized 
by dopamine-elevating drugs (e.g., methylphenidate), accom-
panied by an amelioration of attention performance [11]. First 
publications on children with NF1 plus ADHD (NF1ADHD) 
provide evidence that, similar as in ADHD-only, pharmaceuti-
cal interventions with methylphenidate (MPH) have positive 
eﬀects on the core symptoms of ADHD [17]. Speciﬁcally in 
patients with NF1ADHD, there is tentative evidence that MPH 
might even lead to intellectual improvement [11, 12].
Regarding their cognitive proﬁle, it is well known that 
patients with NF1 do not represent a homogeneous group [5]. 
ere seem to be some combinations of cognitive dysfunc-
tions, which have more impact than others. Especially atten-
tion deﬁcit and ADHD appear to increase the risk for a number 
of other cognitive comorbidities, like deﬁcits in full-scale, 
verbal, and performance-related IQ [13], functional executive 
abilities, sustained attention, receptive language, and academic 
ability (reading, spelling, and mathematical reasoning) [14]. 
e general proﬁle of comorbidities is not too diﬀerent from 
that of patients with ADHD-only, who may, among other con-
ditions, also suﬀer from various learning disabilities and spe-
ciﬁc language impairment [15].
Similar to patients with ADHD-only [15], patients with 
NF1ADHD score signiﬁcantly lower in intelligence tests than 
healthy (sibling-) controls [14–16] and show lower IQ scores 
than NF1 patients without ADHD (NF1-only) [4, 13, 14, 17]. 
Also, speciﬁc learning disabilities and academic underachieve-
ment are associated with ADHD in children, both with and 
without NF1 [14, 16]. e course and proﬁle of cognitive 
impairments seems stable for NF1ADHD as well as for ADHD-
only [16, 18, 19], mediated, however, by the presence or 
absence of T2 signal hyperintensities on MRI for NF1 [20]. 
Executive dysfunctions seem to be a hallmark of both, ADHD-
only and NF1ADHD, including deﬁcits in inhibition, sustained 
attention, verbal ﬂuency, and especially working memory 
deﬁcits, which are well described in both populations [21, 22].
So far, few studies directly compared children with 
NF1ADHD, NF1-only, and ADHD-only [6, 17]. Potvin and col-
leagues retrospectively compared the intellectual proﬁle of 
children with NF1 with and without ADHD and children with 
ADHD-only. ey found that children with NF1 demonstrate 
an uneven intellectual proﬁle with preserved verbal abilities 
and reduced nonverbal abilities, working memory, and pro-
cessing speed. In addition, the combination of NF1 and ADHD 
led to lower performances in most areas of the intelligence test 
WISC-IV than ADHD or NF1 exclusively [17].
Furthermore, the speciﬁc proﬁle of attention functions 
seems to diﬀer between NF1ADHD and ADHD-only: In a treat-
ment study by Mautner and colleagues, children with NF1ADHD 
seemed especially impaired in impulse control, whereas chil-
dren with ADHD-only displayed more deﬁcits in sustained 
attention. Both groups, however, were impaired in response 
time and  variability of response time [6]. A more recent study 
by  Lion-François and colleagues found fundamental qualitative 
and quantitative diﬀerences between the attention deﬁcits of 
NF1ADHD and ADHD-only. Children with NF1ADHD showed 
lower overall performances in the areas of intensive, selective, 
and executive attention, while children with ADHD-only 
showed slower response times in a sustained attention task. e 
authors conclude that the condition NF1ADHD is not only the 
sum of NF1 plus ADHD, and that ADHD symptomatology 
does not contribute to all attention deﬁcits of patients with NF1 
[23]. To back this assumption, however, a NF1 control group 
without ADHD would be needed. Altogether, there is very little 
literature on this particular topic and more studies are needed 
to elucidate diﬀerences and commonalities of the intellectual 
and attention proﬁles of children with NF1ADHD, NF1-only, and 
ADHD-only.
e aim of our study was to compare the intellectual and 
the attention proﬁle of children with NF1ADHD, NF1-only, and 
ADHD-only in a prospective approach. Our study may help 
to substantiate NF1-typical cognitive characteristics and to 
elaborate diﬀerences between NF1ADHD and NF1-only, as well 
as NF1ADHD and ADHD-only:
(1)  Firstly, we assumed that ADHD symptoms are a spe-
ciﬁc risk factor for intellectual functioning in NF1. 
erefore, 
(a)  we expected patients with NF1-only and ADHD-
only to perform signiﬁcantly better on measures of 
intellectual functions than patients with NF1ADHD. 
Additionally,
(b)  we expected intellectual performance to be correlated 
with attention performance in patients with NF1.
(2)  Regarding the attention proﬁle, we expected signiﬁcant 
diﬀerences between NF1-only, NF1ADHD, and ADHD-
only on measures of inattention, hyperactivity, impul-
sivity, and executive functions.
To this end, we recruited patients within the normal and bor-
derline range of intelligence, so that the sample would be rep-
resentative for NF1 and ADHD regarding intelligence.
2. Material and Methods
2.1. Participants. ree groups of patients were recruited 
for this study: (1) patients with NF1ADHD, (2) patients 
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with NF1 without ADHD (NF1control), and (3) patients 
with neurotypical ADHD without NF1 (ADHDcontrol). 
Participants for the NF1 groups were consecutively recruited 
between 2013 and 2016 at the University Children’s Hospital 
Tübingen and the University Medical Center Hamburg-
Eppendorf. For the ADHDcontrol group, all participants 
were recruited at the University Hospital Tübingen. All 
participants were native speakers of the German language. 
NF1 was diagnosed according to the National Institute of 
Health Consensus Development Conference statement 
[24], ADHD was diagnosed according to DSM-IV, based 
on a standardized parent interview by a psychologist, 
questionnaires (Disyps-KJ) [25] and clinical impression 
(observation of the child’s behavior during the assessment). 
Importantly, diagnosis was made independently from any 
test results. Typical psychiatric comorbidities of ADHD and 
NF1 were allowed, e.g. specic developmental disorders of 
speech, language, scholastic skills, motor function, conduct 
disorders or emotional disorders (recorded comorbidities 
and their frequencies in our patient groups are listed in 
Table 1). Patients with evidence for neurological diseases 
with intracranial manifestations (symptomatic optic nerve 
glioma, brain tumor, traumatic brain injury, stroke), or with 
any form of epilepsy, very preterm birth or severe psychiatric 
disorders (e.g., autism spectrum disorders) were excluded.
Altogether, 126 children, aged between 6 and 12 years, were 
recruited. Fi²een participants were excluded a²er the assess-
ment because of comorbid autistic disorders (1 NF1ADHD, 
1 NF1control, 4 ADHDcontrol), falling outside the predened range 
of intelligence (IQ 70–115; 0 NF1ADHD, 1 NF1control, 4 
ADHDcontrol), or—in the ADHDcontrol group—for no longer 
meeting the diagnostic criteria for ADHD at the time of the 
assessment (4 participants).  is le² 53 children in the NF1ADHD
group, 28 in the NF1control group, and 30 in the ADHDcontrol
group for analysis.  irteen participants with NF1 had asymp-
tomatic optic nerve glioma in the absence of other intracranial 
pathology as evidenced by MRI. Nine participants (7 NF1ADHD, 
2 ADHDcontrol) received stimulant medication prior to the 
study, but not on the assessment day, allowing a wash out 
period of ≥24 hours. Approval of the local ethics review board 
Table 1: Sample characterization of patients with NF1ADHD, NF1control, and ADHDcontrol.
Note: a< = “worse than”, even if the score is higher in numbers; ∗푝 < .05; ∗∗푝 < .01; ∗∗∗푝 < .001; b e socio-economic status was measured with the Win-
kler-Index (3–8 = low, 9–14 = middle, 15–21 = high).cData was analyzed with χ2-tests; dData was analyzed with analyses of variance (ANOVA);e Data was ana-
lyzed with multivariate analyses of covariance (MANCOVA). fADHD-C = combined type of ADHD, ADHD-I = inattentive type of ADHD.
Corrected means (standard error)
NF1ADHD (A) NF1control (B) ADHDcontrol (C) 퐹 (all groups)a 푀푆퐸 푝 values  (all groups) Post-hoc comparisons
a
Number 53 28 30 — — — —
Sex (female/male) 20/33 18/10 8/22 — — 0.010c —
Age 8.87 (0.20) 8.36 (0.28) 8.96 (0.27) 1.454 2.175 0.238d —
SES (Winkler-index)b 12.02 (0.64) 13.39 (0.86) 11.13 (0.80) 1.88 18.99 0.159d —
Familial type of NF1 
(familial/
spontaneous)
25/28 9/19 — — — 0.240c —
Asymptomatic optic 
nerve glioma (N) 10 3 — — — 0.358
c —
Subtype (ADHD-C/
ADHD-I)f 33/20 — 16/14 — — 0.490
c —
Methylphenidate 
prior to T1 (N) 7 — 2 — — 0.292
c —
Conners 3® ADHD-
index (T-scores)
62.48 (0.86) 52.93 (1.27) 66.05 (1.07) 31.29 33.58 <0.001∗∗∗e A<B∗∗∗; C<B∗∗∗; C<A∗
Conners 3® global-in-
dex (T-scores) 60.22 (1.16) 49.61 (1.72) 65.03 (1.46) 23.17 61.78 <0.001
∗∗∗e A<B∗∗∗; C<B∗∗∗; C<A∗
Allowed 
comorbidities Number of patients
푝 values (all 
groups) Post-hoc comparisons
a
Previous language 
disorder 14 4 7 — — .415
c —
Unspecic learning 
disabilities 9 1 1 — — .108
 c —
Dyslexia 8 1 6 — — .188 c —
Dyscalculia 5 0 3 — — .519 c —
Depression 0 0 1 — — .538 c —
Anxiety disorders 1 1 1 — — .457 c —
Oppositional deant 
disorder 4 0 3 — — .325
 c —
Conduct disorder 2 0 2 — — .325 c —
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signicantly between the groups. ADHD  subtype did not dier 
signicantly between the two ADHD groups. Patient groups 
diered signicantly on the ADHD-index and the Global-index 
of the Conners 3®, with signicantly higher scores for both 
ADHD groups than for the NF1control group and signicantly 
more profound ADHD symptoms in the ADHDcontrol group than 
in the NF1ADHD group.
Regarding the intellectual prole, there was a signicant 
main eect for group on full-scale-IQ (퐹(2, 111) = 12.031, 
푀푆퐸 = 103.06, 푝 < .001), while the covariates sex and age did 
not have a signicant eect on the dependent variable. Planned 
pairwise comparisons showed that the NF1ADHD group scored 
signicantly lower than the NF1control group and the 
ADHDcontrol group (Figure 1).
 e MANCOVA for the WISC-IV subscales revealed a 
signicant eect of the covariate sex on processing speed 
(퐹(1, 111) = 8.064, 푝 = .005), with girls performing better on 
processing speed than boys in both ADHD groups. A²er cor-
recting for the eect of the covariate, signicant main eects 
were observed for all four WISC-IV subscales (verbal com-
prehension: 퐹(2, 111) = 5.498, 푀푆퐸 = 106.80, 푝 = .005; 
 perceptual reasoning: 퐹(2, 111) = 5.094, 푀푆퐸 = 137.36, 
푝 = .008; working memory: 퐹(2, 111) = 7.858 , 푀푆퐸 = 131.03 , 
푝 = .001; processing speed: 퐹(2, 111) = 5.842, 푀푆퐸 = 163.78, 
푝 = .004), with the NF1ADHD group performing signicantly 
worse than the NF1control group on all subscales and also per-
forming worse than the ADHDcontrol group on the subscale 
working memory (Table 2). Between the NF1control group and 
the ADHDcontrol group, there were no signicant dierences.
 e bias corrected second-order partial correlation anal-
ysis revealed a signicant positive relationship between the 
API and the full-scale IQ (푟 = .408, BCa CI [.255, .549], 
푝 < .001) for the combined NF1 sample (Figure 2).
 e MANCOVA for the attention prole showed signi-
cant eects of the covariates full-scale IQ (퐹(4, 111) = 5.208, 
푝 = .001) and sex (퐹(4, 111) = 7.842,푝 < .001). A²er account-
ing for the eects of the covariates, there was no signicant 
main eect of group on the parameters of the T.O.V.A. 
(Table 2).  e comparison of frequencies of subnormal per-
formances on the parameters of the T.O.V.A. showed signi-
cantly more reduced performances in the NF1ADHD group on 
Omission Errors compared to the ADHDcontrol group (Pearson 
χ2  (1, 푁 = 83) = 6.422, 푝 = 013). Also, the NF1ADHD group 
showed signicantly more reduced performances on response 
time variability (Pearson χ2 (1, 푁 = 81) = 5.781, 푝 = .020) and 
omission errors (Pearson χ2 (1, 푁 = 81) = 6.658, 푝 = .011) than 
the NF1control group. Between the ADHDcontrol group and the 
NF1control group, there were no signicant dierences on any 
parameter of the T.O.V.A. regarding the frequencies of sub-
normal performances (Figure 3).
For the Conners 3®, data of 4 patients were missing. In the 
analysis of the Conners 3®, there was a signicant eect of the 
covariate sex on inattention (퐹(1, 107) = 8.607, 푝 = .004), with 
girls being rated as more inattentive than boys in both ADHD 
groups. Full-scale IQ and age were not related to group dier-
ences on the Conners 3® subscales. A²er correcting for the 
eect of sex, signicant main eects for group were found on 
the subscales inattention (퐹(2, 107) = 37.877, 푀푆퐸 = 34.87, 
푝 < .001) and Hyperactivity/Impulsivity (퐹(2, 107) = 13.146, 
(655/2012BO1), patients’ assent and written informed consent 
of their caregivers were obtained prior to the investigations.
2.2. Materials. All participants underwent a neuropediatric 
and neuropsychological assessment, including the German 
Wechsler intelligence scales for children (WISC-IV) [29] 
and the Test of Variables of Attention (T.O.V.A.®) [28]. 
Additionally, functional aspects of attention were measured 
with a behavioral rating scale for parents (Conners 3®) [26]. 
Everyday aspects of executive functioning were measured with 
the questionnaire BRIEF® [27] (parent version).
 e socio-economic status (SES) was measured with the 
Winkler-Index [30], taking into account the parents’ educa-
tional achievement, their professional position and family 
income.
2.3. Data Analyses. Data were analyzed using the 25th version 
of the IBM Statistical Package for Social Science (SPSS). 
Group (NF1ADHD; NF1control; ADHDcontrol) served as between 
subject factor and full-scale IQ, sex, and age as covariates, 
where appropriate. Due to high intercorrelation, full-scale IQ 
was excluded as covariate from the analysis on the WISC-
IV subscales.  e level of signicance was set at 푝 < 0.05 for 
all tests and adjusted by Bonferroni corrections for multiple 
comparisons.  ere were no relevant missing data (missing data: 
8 participants for the SES, 4 participants for the Conners 3®), 
and the aected cases were excluded from the analyses.
To explore hypothesis one, data of the full-scale IQ and of 
all subscales of the WISC-IV (verbal comprehension, percep-
tual reasoning, working memory, and processing speed) were 
analyzed for group dierences with two-tailed univariate and 
multivariate analyses of covariance ((M) ANCOVAs). 
Additionally, the correlation between full-scale IQ and atten-
tion performance index (API) of the T.O.V.A. was tested across 
both NF1 groups with a second-order partial correlation anal-
ysis (Pearson’s correlation coecient).
To test our second hypothesis, all parameters of the 
T.O.V.A. (Response Time Variability, Response Time, 
Commission Errors, and Omission Errors) and the subscales 
Inattention and Hyperactivity/Impulsivity of the Conners 
3® were tested for group dierences with two-tailed multi-
variate analyses of covariance (MANCOVAs).  e global 
executive composite (GEC) score (=total score), the 
Behavioral Regulation Index, and the Metacognition Index 
of the BRIEF® were tested for group dierences with a two-
tailed univariate and a two-tailed multivariate analysis of 
covariance ((M)ANCOVAs). Additionally, frequencies of 
subnormal performances (scores <85) on the parameters of 
the T.O.V.A. were compared between the ADHD patient 
groups with nonparametric chi-square tests. NF1 patients 
without ADHD were included in the analyses as a control 
group.
3. Results
Table 1 summarizes the data of the explorative analyses for group 
characterization.  ere were no signicant dierences between 
the groups regarding age and SES, while sex distribution diered 
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4.1. Intellectual Prole. Consistent with previous research [13, 
17], we found that patients with NF1ADHD showed the lowest 
IQ scores of all three groups and diered signicantly from 
patients with NF1control in all measured areas of intellectual 
ability (Figure 1). Even though mean scores of all scales of 
the intelligence test lay within normal limits for the NF1ADHD
group, there seem to exist intellectual challenges in this group, 
which may not represent a serious disability, but could still 
crucially in¾uence long-term adaptive functioning and 
participation. Furthermore, in NF1, reduced intellectual 
functioning correlated with reduced attention functions as 
measured with the T.O.V.A. attention performance index 
(API). From this nding we conclude that even subclinical 
attention problems are negatively associated with intellectual 
performance (Figure 2). While this correlation does not have 
the potential to re¾ect the multidimensional interactions 
between specic attention functions with specic intellectual 
푀푆퐸 = 79.06, 푝 < .001) of the Conners 3®. Planned pairwise 
comparisons showed that both ADHD groups were rated sig-
nicantly worse than the NF1control group on Inattention and 
Hyperactivity/Impulsivity, but did not dier signicantly from 
each other (Table 2).
For the BRIEF®, data of 33 patients (24 NF1ADHD, 9 NF1control, 
and 0 ADHDcontrol) were missing, because the questionnaire 
BRIEF® was not applied to patients that were assessed in the 
University Medical Center Hamburg-Eppendorf.  e analyses of 
the BRIEF® scales showed a signicant eect of group for the GEC 
score (퐹(2, 78) = 15.382, 푀푆퐸 = 93.30, 푝 < .001) and for the 
behavioral regulation index (퐹(2, 78) = 6.117, 푀푆퐸 = 133.85, 
푝 = .004), as well as the metacognition index (퐹(2, 78) = 17.843, 
푀푆퐸 = 97.06, 푝 < .001).  e covariates full-scale IQ, sex, and age 
had no in¾uence on the dependent variables. Planned pairwise 
comparisons revealed that the NF1control group was rated as 
signicantly better than both other groups on the GEC score and 
the metacognition index. Additionally, the NF1control group was 
rated as signicantly better on the behavioral regulation index 
than the ADHDcontrol group (Table 2). Between the NF1ADHD
group and the ADHDcontrol group, there were no signicant 
dierences.
4. Discussion
Our study on the intellectual and attention proles of NF1ADHD, 
NF1control, and ADHDcontrol yielded two main ndings: Firstly, 
as predicted by our rst hypothesis and complementing pre-
vious publications, the NF1 group in our sample could be 
divided in two distinct subgroups: A comorbid diagnosis of 
ADHD does seem to make a marked dierence in the prole 
of intellectual and attention performance in patients with NF1. 
More specically, an index of attention performance was 
closely associated with intellectual performance in NF1. 
Secondly, we could identify some qualitative dierences 
between the attention performance of ADHD-patients with 
and without NF1, and also between NF1-patients with and 
without ADHD.
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Figure 1: Intellectual prole of the intelligence test WISC-IV; standard scores (mean = 100; SD = 15).
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Figure 2: Correlation between full-scale IQ and attention perfor-
mance index for combined NF1 sample.
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memory skills (scores below the normal range) compared to 
10.7 percent in the NF1control group and 10.0 percent in the 
ADHDcontrol group. Our results suggest that problems in exec-
utive functioning and short-term memory are associated with 
NF1, but also that these problems are exacerbated by additional 
ADHD symptoms. Since our measures on other executive func-
tions apart from working memory were retrieved from ques-
tionnaires, a dierentiated prole of executive decits could not 
be evaluated, and our assumptions must stay on a global level. 
However, a simple summation of negative eects of NF1 and 
ADHD symptoms on working memory skills in NF1ADHD is 
unlikely considering the low numbers of patients with NF1-only 
and ADHD-only showing reduced working memory skills in 
our study. Apparently it is the combination of NF1 and ADHD 
that leads to an additional cognitive burden.
One very interesting nding of our study is that patients 
with NF1control scored, as a group, at the population mean of 
intellectual functioning, which somewhat contradicts the 
functions, it provides a hint that the intellectual dierence 
between the two NF1-groups is not just the result of behavioral 
or motivational problems inherent to the ADHD-condition, 
but that there is a true neuropsychological correlate which 
needs to be investigated more thoroughly.
Regarding the prole of intellectual abilities, we found an 
uneven prole in patients with NF1, similarly to Potvin et al., 
[17].  e NF1ADHD group showed a parallel pattern to the 
NF1control group with better verbal than visual-spatial skills 
and processing speed, and with the most intense weakness in 
working memory.  ese ndings dier slightly from the 
results of Potvin and colleagues.  ey found the most pro-
nounced weakness in processing speed in patients with NF1-
only (and with ADHD-only).
In the present study, working memory had the lowest scores 
of the subscales of the WISC-IV in all three patient groups, but 
the performance was far more decreased in the NF1ADHD group. 
In the NF1ADHD group, 47.2 percent showed impaired working 
Table 2: Attention prole and intellectual prole of patients with NF1ADHD, NF1control, and ADHDcontrol.
Note: aFull-scale IQ was analysed with an univariate analysis of covariance (ANCOVA), all other data was analyzed with multivariate analyses of covariance  
(MANCOVAs); b< = “worse than”, even if the score is higher in numbers; ∗푝 < .05; ∗∗푝 < .01; ∗∗∗푝 < .001; cFor the Conners 3®, data of to 4 patients was 
missing; d For the BRIEF®, data of 33 patients were missing (included were 29 NF1ADHD, 19 NF1control, and 30 ADHDcontrol patients).
Corrected means (standard error)
NF1ADHD (A) NF1control (B) ADHD
control 
(C) 퐹 (all groups)
a 푀푆퐸 푝 (all groups) 휂2 Post-hoc com-parisonsb
WISC-IV 
(standard score) 퐹(2, 111)
Full-scale IQ 89.39 (1.40) 101.14 (1.98) 95.12 (1.88) 12.031 103.06 <0.001∗∗∗ 0.185 A<B∗∗∗; A<C∗
WISC-IV 
subscales 
(standard scores)
퐹(2, 111)
Verbal 
comprehension 95.58 (1.42) 103.77 (2.02) 99.03 (1.91) 5.498 106.80 0.005
∗∗ 0.094 A<B∗∗
Perceptual 
reasoning 91.93 (1.61) 100.93 (2.29) 95.12 (2.17) 5.094 137.36 0.008
∗∗ 0.088 A<B∗∗
Working memory 87.62 (1.58) 97.37 (2.24) 95.03 (2.12) 7.858 131.03 0.001∗∗ 0.129 A<B∗∗, A<C∗
Processing speed 91.33 (1.76) 101.85 (2.50) 95.09 (2.37) 5.842 163.78 0.004∗∗ 0.099 A<B∗∗
T.O.V.A. 
(standard scores) 퐹(2, 111)
Variability 84.57 (2.54) 92.34 (3.65) 81.17 (3.62) 2.610 309.25 0.078 0.047 —
Response time 91.44 (2.56) 93.92 (3.68) 84.47 (3.29) 2.166 315.23 0.120 0.040 —
Commission 
errors 95.43 (2.60) 98.92 (3.74) 95.61 (3.35) 0.296 325.44 0.745 0.006 —
Omission errors 72.26 (3.28) 83.06 (4.71) 81.57 (4.21) 2.252 516.10 0.110 0.041 —
Conners 3® 
(T-scores)c 퐹(2, 107)
“Inattention” 65.23 (0.87) 54.02 (1.29) 68.62 (1.09) 37.877 34.87 <0.001∗∗∗ 0.429 A<B∗∗∗; C<B∗∗∗
Hyperactivity/
impulsivity 59.56 (1.32) 48.80 (1.94) 61.41 (1.65) 13.146 79.06 <0.001
∗∗∗ 0.207 A<B∗∗∗; C<B∗∗∗
BRIEF® 
(T-scores)d 퐹(2, 78)
GEC score 61.83 (1.92) 47.80 (2.48) 64.86 (1.79) 15.382 93.30 <0.001∗∗∗ 0.999 A<B∗∗∗; C<B∗∗∗
Behavioral 
regulation index 57.08 (2.30) 47.87 (2.97) 60.87 (2.16) 6.117 133.85 0.004
∗∗ 0.876 C<B∗∗
Metacognition 
index 64.28 (1.96) 48.22 (2.53) 66.82 (1.84) 17.843 97.06 <0.001
∗∗∗ 1.000 A<B∗∗∗; C<B∗∗∗
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executive functions. At rst sight, however, data of the 
T.O.V.A. and of the parent rating scales (Conners 3® and 
BRIEF®) provide a comparable picture in the two ADHD 
groups with moderate inattention, mild hyperactivity/
impulsivity, and mild executive dysfunction.  e attention 
prole of the NF1control group reveals mild inattention (i.e., a 
subnormal mean score on omission errors in the T.O.V.A.), 
but no decits in hyperactivity/impulsivity or executive 
functions. No signicant dierences between mean scores 
of specic attention domains were found. However, a closer 
look into the samples reveals a more detailed picture.
Both ADHD groups presented slightly subnormal mean 
scores on response time variability (re¾ecting distractibility) 
and omission errors (re¾ecting inattention), but additionally, 
the ADHDcontrol group showed a reduced performance on 
response time.  ese results are in line with the ndings of a 
recent study, where neurotypical patients with ADHD showed 
inferior response times to patients with NF1ADHD in a sus-
tained attention task [23].
 e frequencies of subnormal performances show an 
important and signicant dierence between patients with 
ADHD with and without NF1 in the T.O.V.A. Nearly twice as 
many patients with NF1ADHD (62.3%) than patients with 
ADHDcontrol (33.3%) showed subnormal performances on 
Omission Errors (re¾ecting inattention). Response Time 
Variability was also more o²en reduced in the NF1ADHD group 
than in the ADHDcontrol group, even though there were no 
signicant dierences.
Overall, the signicantly higher number of patients with 
impaired performance on Omission Errors in the NF1ADHD
group is also re¾ected in the mean scores and these results 
together lead to the strong assumption that the attention pro-
les of patients with NF1ADHD dier from those of patients 
with ADHDcontrol. Patients with NF1ADHD seem to be especially 
aected regarding inattention, as is the case with patients with 
consistent ndings of earlier research of generally reduced 
intellectual functioning in NF1 [3]. However, most prior 
studies reporting a generalized downward shi² of IQ in NF1 
treated the population as one homogeneous group. More 
recent studies, however, considered a possible negative in¾u-
ence of attention decit on intellectual functioning and 
therefore dierentiated between patients with and without 
ADHD within the NF1 population.  ese studies indicate 
that ADHD is a potential risk factor for intellectual dysfunc-
tion. Two retrospective studies analyzing clinical patient data 
provided rst evidence for an additional cognitive burden of 
patients with NF1ADHD [13, 17]. Our study now conrmed 
and extended these results prospectively in a more represent-
ative sample. One possible interpretation of this nding is a 
direct in¾uence of attention problems on the acquisition of 
skills and knowledge, or, even more simply, on the perfor-
mance in intelligence tests. However, given the multi-faceted 
neurocognitive prole of NF1, and the complexity of the 
attention domain, this assumption is likely insucient. With 
attention decit being only one in a spectrum of NF1-related 
neurodevelopmental problems, a common cause in the neu-
robiological basis of NF1 is highly probable, leading to a 
range of cognitive decits down the stream of aberrant neural 
pathways and altered neurotransmitter systems.  e combi-
nation of these two aspects, supplemented by adaptive devel-
opmental processes, might account for the apparently 
categorical distribution of cognitive proles between NF1 
with or without ADHD symptoms.
4.2. Attention Prole. In the neurotypical population, ADHD 
is a heterogeneous condition with a variety of proles in 
attention and executive functions [31]. Assuming that 
ADHD symptoms are the endpoint of a more uniform 
neurobiological pathway in NF1, we expected both NF1 
groups to exhibit a more concise prole of attention and 
Variability
Response time
Commission errors
Omission errors
0 20 40 60 80
NF1-ADHD
ADHD-control
NF1-control
15.8 %
In %:
Figure 3: Frequencies of subnormal performance in percent.
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attention and also executive functions and to gain a more 
detailed picture of the proﬁles of ADHD in NF1 and 
ADHD-only.
Regarding executive dysfunctions, there is a limitation in 
that we only used external ratings of everyday functioning and 
no test measures to assess them. As a consequence, we have a 
high rate of missing data for this area. For a comprehensive 
evaluation of executive functions further studies should 
include both types of measurement, since it is well known that 
data of external ratings and test measures have the tendency 
to diﬀer from each other [35] and are suspected to tap diﬀerent 
executive functions [36].
Another limitation is that we investigated three patient 
groups of very diﬀerent group sizes, which might limit the 
statistical power of our analyses and might aﬀect type II error 
rates. Additionally, the ADHDcontrol group was rather small 
considering the prevalence of ADHD. erefore, it was not 
possible to diﬀerentiate between ADHD subtypes in our 
patient groups. Even though the distribution of subtypes did 
not diﬀer signiﬁcantly between the NF1ADHD group and the 
ADHDcontrol group, slight diﬀerences in the frequency of the 
subtypes could have had an eﬀect on the results. Moreover, we 
cannot contribute to the open questions of diverse distribu-
tions of ADHD symptoms and ADHD subtypes in NF1 and 
ADHDcontrol. Also, the sex distribution was uneven in all three 
patient groups and was nearly reversed in the ADHDcontrol 
group compared to the NF1control group. Even though we used 
sex as a covariate in our analyses, the qualitative diﬀerences 
between boys and girls regarding ADHD symptomatology and 
eventually also cognitive dysfunction in NF1 could still have 
inﬂuenced our results.
5. Conclusion
First of all, our ﬁndings support the hypothesis that NF1 per 
se might not lead to globally impaired intellectual functioning, 
but that attention deﬁcits are a speciﬁc additional risk factor 
for suboptimal intellectual performance in NF1, like ADHD 
is in the general population [15]. Second, our results show that 
the frequency of deﬁcits in speciﬁc attention domains of 
NF1ADHD diﬀers from that of ADHD-only, which goes along 
with a diﬀerent distribution of ADHD subtypes in the two 
groups. Both ﬁndings indicate that ADHD in NF1 is not only 
a simple comorbidity and that the condition NF1ADHD comes 
with an additional cognitive burden. Furthermore, there seem 
to exist (subclinical) attention deﬁcits in NF1, which are rather 
associated with the NF1 condition than with a comorbid 
ADHD diagnosis. Assuming that there are—at least—two 
distinct proﬁles of NF1 with one group being more aﬀected 
than the other, this would encourage further investigations on 
neurobiological causes of cognitive dysfunction in NF1 and 
entail implications for potential treatment options [11, 37].
Data Availability
e statistical data used to support the ﬁndings of this study 
are included within the article. Additional statistical data or 
NF1 without ADHD. Our results conﬁrm previous research 
showing that symptoms of inattention are more prevalent in 
NF1 [14] and they support the idea that certain deﬁcits are 
rather associated with NF1 than merely the result of an comor-
bid ADHD symptomatology [32, 33].
Even if there is still a marked diﬀerence between NF1 
patients with and without an additional ADHD diagnosis, the 
number of below average performances in the NF1control group 
is high, especially in the areas of distractibility and inattention. 
Furthermore, there were no statistical diﬀerences between 
patients with NF1-only and patients with ADHD-only in the 
frequencies of subnormal performances. Altogether, this leads 
to the conclusion that subclinical attention problems are prev-
alent among patients with NF1 without an ADHD diagnosis 
and might be an inherent cognitive feature of the NF1 condi-
tion. Aﬀected inattention/sustained attention in patients with 
NF1 was found before [14], but aﬀected performances in other 
areas of attention functions are an unexpected and novel ﬁnd-
ing that requires further investigation.
e heterogeneity of the incidence of subclinical attention 
problems or ADHD in the NF1 population might be explained 
by diﬀerent phenotype expressions. Even if NF1 is a monoge-
netic disorder, this does not mean that it is a homogeneous 
medical condition. Evidence rather suggests that factors like 
sex, age, speciﬁc cell type, genomic modiﬁers, and micro-en-
vironmental inﬂuences determine the cognitive and behavio-
ral phenotype triggered by the NF1 condition. Diﬀerent levels 
of Ras (Rat sarcoma) and dopamine activity in speciﬁc com-
binations are proposed to contribute to diverse cognitive pro-
ﬁles in NF1: High levels of Ras activity plus slightly reduced 
levels of dopamine might lead to severe spatial learning and 
memory deﬁcits, while high levels of Ras activity plus heavily 
reduced levels of dopamine might result in severe attention 
problems and mild learning deﬁcits [10]. Additionally, to elu-
cidate the role of Ras, dopamine or other neurotransmitters 
on learning, memory, and attention deﬁcits in NF1, further 
research is needed.
4.3. Limitations. Some limitations have to be considered in 
the interpretation of our results. We acknowledge that we 
partly recruited patients, who had an indication for clinical 
neuropsychological diagnostics because of developmental, 
behavioral, or academic problems. erefore, the intellectual 
and attention performance of these patients might be worse 
than that of other patients with NF1 or ADHD. Additionally, 
we excluded NF1 patients with intracranial complications, 
which might limit the representativeness of our NF1 patient 
group. However, since intracranial complications in NF1 (e.g., 
intracranial tumors with 1-2% or hydrocephalus with 2% [34]) 
are rare, the results of our study should still be valuable for the 
majority of patients with NF1.
Furthermore, we used only one continuous performance 
test and one attention questionnaire to assess the attention 
proﬁle of our patients. Although the T.O.V.A. test is very 
good in predicting ADHD in individuals, it might not meas-
ure speciﬁc attention functions diﬀerentiated enough to dis-
tinguish between ADHD in NF1 and ADHD-only. For 
further studies on this topic the use of more elaborate test 
batteries is recommended, to address diﬀerent domains of 
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